In this study, HER2 positive were 55.49% and 9.46% in southern China and SEER cohort respectively (P = 0.000), which was consistent with the literature showing that BC cells from young patients are more likely to show HER2 positive expression24. This evidence concerns the gene ERBB2 and breast cancer.